Accessibility Menu
Cerus logo

Cerus

(NASDAQ) CERS

Current Price$3.15
Market Cap$627.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-74%
5 Year-36%
1 Year+128%
1 Month+22%
Cerus last closing stock price
MetricPriceDate
Last closeUSD 3.132026-07-17
Cerus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.32%USD 3.122026-07-10
1 month+21.79%USD 2.572026-06-17
3 month+50.48%USD 2.082026-04-17
Year to date+51.94%USD 2.062025-12-31
1 year+128.47%USD 1.372025-07-17
3 year+13%USD 2.772023-07-18
5 year-35.99%USD 4.892021-07-16
Since inception-74.19%USD 12.131997-01-31

Cerus Financials at a Glance

Market Cap

$627.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$222.79M

Net Income (TTM)

-$9.55M

EPS (TTM)

-$0.05

P/E Ratio

-62.98

Dividend

$0.00

Beta (Volatility)

1.75 (High)

Price

$3.15

Volume

1,921,473

Open

$3.13

Previous Close

$3.15

Daily Range

$3.11 - $3.23

52-Week Range

$1.15 - $3.47

Estimated Earnings Date

Aug 4, 2026

CERS News

stock-up-bar-chart-getty

Here's Why Cerus Corporation Stock Popped Today

Cory RenauerOct 16, 2018
happy-young-woman-stock-chart-getty

Here's Why Cerus Corporation Stock Is Surging Today

Cory RenauerMay 9, 2018
chart-going-up-with-dollar-signs-getty

Here's Why Cerus Corporation Stock Popped Today

Cory RenauerJan 24, 2018
woman making money

Here's Why Cerus Corporation Rose as Much as 23.6% Today

Maxx ChatskoNov 3, 2017
Cheap Stocks

Why Cerus Corporation Stock Marched Higher Today

George Budwell, PhDOct 5, 2017
woman making money

Here's Why Cerus Corporation Rose as Much as 17.4% Today

Maxx ChatskoJun 7, 2017
woman walking through arrow

Here's Why Cerus Corporation Rose as Much as 16.3% Today

Maxx ChatskoMay 26, 2017
money falling through hands

Here's Why Cerus Corporation Stock Is Tanking Today

Brian FeroldiMay 23, 2017
Page 1

CERS: Motley Fool Moneyball Superscore

58

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cerus

Cerus makes products that clean donated blood for patients. Its systems stop germs from growing in blood components. This helps hospitals provide safer transfusions to people.

The Blood Safety Kit

  • Platelet and Plasma Systems: Disposable kits and light devices used to reduce pathogens in blood components; sold across North America, Europe, and the Middle East.
  • Fibrinogen Complex: Specialized blood product used to treat and control massive bleeding in hospital settings.
  • Illumination Devices: Hardware that uses ultraviolet light to activate the blood cleaning process.
  • Red Blood Cell System: Technology currently in clinical development to expand the pathogen-reduction platform to red blood cell transfusions.

Growth and Partnership Moves

  • Entered a manufacturing agreement with Fresenius Kabi AG in May 2022 to produce disposable sets through 2031.
  • Signed a new contract with BARDA in September 2024 for up to $32 million to develop red blood cell treatments.
  • Expanded a U.S. Department of Defense agreement in July 2025 to increase trauma treatment funding to $25 million.
  • Established a joint venture with Shandong Zhongbaokang Medical Implements in 2021 to enter the Chinese medical market.

Global Reach and Innovation

Cerus operates a specialized distribution network that serves blood banks and hospitals across North America, Europe, and Latin America. The company leverages long-term government contracts to fund the high costs of clinical trials for new medical devices.

Financial Performance Trajectory

  • Revenue reached $59.9 million in Q1 2026, up 38.5% from $43.2 million in Q1 2025.
  • Gross profit was $34.1 million in Q1 2026, up 34.2% from $25.4 million in Q1 2025.
  • Net loss narrowed to $1.6 million in Q1 2026, an improvement from $7.7 million in Q1 2025.
  • Free cash flow hit negative $3.3 million in Q1 2026, worsening from negative $956,000 in Q1 2025.
  • Operating income improved to negative $354,000 in Q1 2026, up from a $11.5 million loss in Q1 2025.

The Final Word

Cerus has evolved from a development-stage company into a commercial provider of essential blood safety technology. Its business model relies on expanding regulatory approvals and deep integration with national blood supply systems.

AI Generated • May 5, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

275

CEO

Obi Greenman

Website

www.cerus.com

Headquarters

Concord, CA 94520, US

CERS Financials

Key Financial Metrics (TTM)

Gross Margin

54.31%

Operating Margin

-7.94%

Net Income Margin

-4.29%

Return on Equity

-15.36%

Return on Capital

-22.55%

Return on Assets

-4.28%

Earnings Yield

-1.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$627.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

200.37M

Volume

1.92M

Avg. Volume

2.75M

Financials (TTM)

Gross Profit

$120.99M

Operating Income

-$17.69M

EBITDA

$1.19M

Operating Cash Flow

$2.63M

Capital Expenditure

-$3.85M

Free Cash Flow

-$1.22M

Cash & ST Invst.

$80.43M

Total Debt

$97.36M

Cerus Performance Analysis

Cerus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 162,048,00023.8%
20232023-12-31USD 156,367,000-3.5%
20242024-12-31USD 180,270,00015.3%
20252025-12-31USD 206,133,00014.3%
Cerus sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3021.3%
Q32025-09-300.5%
Q42025-12-319.6%
Q12026-03-313.7%
Cerus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.24-23.7%
20232023-12-31USD -0.21-14.2%
20242024-12-31USD -0.11-45.5%
20252025-12-31USD -0.08-27.6%
Cerus sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3027.7%
Q32025-09-3099.7%
Q42025-12-31-11300.0%
Q12026-03-3112.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$59.89M

+38.5%

Gross Profit

$34.13M

+34.2%

Gross Margin

56.98%

N/A

Market Cap

$627.16MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.28M

N/A

Employees

275

N/A

Net Income

-$1.64M

+78.7%

EBITDA

$762.00K

+114.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$80.43M

-0.6%

Total Debt

$97.36M

-2.1%

Accounts Receivable

$29.32M

+11.3%

Inventory

$61.12M

+26.9%

Long Term Debt

$41.82M

-45.6%

Short Term Debt

$55.54M

+145.4%

Return on Assets

-4.28%

N/A

Return on Invested Capital

-15.32%

N/A

Free Cash Flow

-$3.28M

-243.3%

Operating Cash Flow

-$3.05M

-261.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NPCENeuroPace, Inc.
$15.75-2.05%
MASS908 Devices Inc.
$7.03-4.35%
TKNOAlpha Teknova, Inc.
$5.30-2.21%
SGHTSight Sciences, Inc.
$5.04+0.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
PATHUiPath
$12.16+0.00%
ZYBTZhengye Biotechnology
$8.01+10.48%
IRENIren
$40.20+0.20%
HLHecla Mining
$14.29-0.00%

Questions About CERS

What is the current price of Cerus?

Cerus is trading at $3.15 per share.

What is the 52-week range for Cerus?

Over the past 52 weeks, Cerus has traded between $1.15 and $3.47.

How much debt does Cerus have?

As of the most recent reporting period, Cerus reported total debt of $97.36M.

How much cash does Cerus have on hand?

Cerus reported $27.85M in cash and cash equivalents in its most recent financial results.

What is Cerus’s dividend yield?

Cerus does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services